Literature DB >> 31197693

Hybrid Laparoscopic and Robotic Hepatopancreaticoduodenectomy for Cholangiocarcinoma.

Eui Hyuk Chong1, Sung Hoon Choi2.   

Abstract

INTRODUCTION: Combined hepatic resection and pancreaticoduodenectomy is the treatment of choice for patient with extensive horizontal-spreading cholangiocarcinoma involving both the perihilar bile duct and the intrapancreatic distal bile duct.1-3 This surgical procedure is extremely complex, and incurs a high risk of postoperative morbidity and mortality.4 However, in recent years, this complicated high-risk operation can be safely performed in well-selected patients.5 However, as we know, none of these operations have been reported as minimally invasive surgery. PATIENT AND METHODS: A 73-year-old female presented with jaundice and was diagnosed with cholangiocarcinoma. The preoperative image studies revealed a 4.3-cm-long diffuse, infiltrative cholangiocarcinoma from the hilar bile duct to the intrapancreatic bile duct without major vascular invasion. The patient was scheduled to undergo left hepatectomy with caudate lobectomy and pancreaticoduodenectomy to obtain a free resection margin. In order to maximize the efficiency of each surgical modality, we designed a hybrid method of laparoscopic resection and robotic reconstruction for this complicated surgery with a long operation time. A 12-mm port was placed at the subxiphoid area, which was utilized for laparoscopic CUSA during the liver resection. Three 12-mm ports around the umbilicus and an 8-mm robotic port at the right flank were placed. In the resection phase, pancreaticoduodenectomy was performed first, followed by hilar dissection and liver resection in en bloc manner. Here, a hanging maneuver was helpful for the complete resection of the caudate lobe in environment with the large specimen attached. In reconstruction phase, the right flank 8-mm port and the left side 12-mm port (using the double docking technique) were used for docking of two robotic working arms.
RESULTS: The total operation time was 510 min, and the estimated blood loss was 350 mL without transfusion. The patient's postoperative recovery was smooth, except for a mild fever due to cystitis, and she was discharged on the 16th postoperative day. Permanent pathologic examination revealed a disease-free proximal bile duct margin, but a metastasis was discovered in one regional lymph node metastasis from 18 retrieved lymph nodes. The patient is receiving adjuvant gemcitabine chemotherapy and regular surveillance. We performed two consecutive cases and the perioperative outcomes were summarized in the attached video.
CONCLUSION: Hepatopancreaticoduodenectomy has a long operative time, involves complicated anatomical structures and difficulty of R0 resection, and it is a remaining frontier of minimally invasive surgery. However, we expect that highly selected patients can carefully undergo minimally invasive surgery if the advantages of the currently available surgical methods are well utilized.

Entities:  

Keywords:  Cholangiocarcinoma; Hepatopancreaticoduodenectomy; Laparoscopic; Minimally invasive; Robotic

Mesh:

Year:  2019        PMID: 31197693     DOI: 10.1007/s11605-019-04242-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  5 in total

1.  Hepatopancreaticoduodenectomy for Biliary Cancer: Strategies for Near-zero Operative Mortality and Acceptable Long-term Outcome.

Authors:  Taku Aoki; Yoshihiro Sakamoto; Yoshiharu Kohno; Nobuhisa Akamatsu; Junichi Kaneko; Yasuhiko Sugawara; Kiyoshi Hasegawa; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  Ann Surg       Date:  2018-02       Impact factor: 12.969

2.  Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project.

Authors:  Thuy B Tran; Monica M Dua; David A Spain; Brendan C Visser; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2015-06-08       Impact factor: 3.647

3.  Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients.

Authors:  Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Yuji Nimura; Masato Nagino
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

Review 4.  Safety and outcome of combined liver and pancreatic resections.

Authors:  P Addeo; E Oussoultzoglou; P Fuchshuber; E Rosso; C Nobili; S Langella; D Jaeck; P Bachellier
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939

5.  Indication of hepatopancreatoduodenectomy for biliary tract cancer.

Authors:  Seiko Hirono; Masaji Tani; Manabu Kawai; Shinomi Ina; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

  5 in total
  4 in total

1.  Which one is better? Laparoscopic versus robotic reconstruction in the remnant soft pancreas with a small pancreatic duct following pancreaticoduodenectomy: a multicenter study with propensity score matching analysis.

Authors:  Jae Young Jang; Chang Moo Kang; Hyeyeon Kim; Munseok Choi; Jae Hoon Lee; Sung Hoon Choi
Journal:  Surg Endosc       Date:  2022-09-12       Impact factor: 3.453

2.  Laparoscopic hepatopancreaticoduodenectomy for synchronous gallbladder cancer and extrahepatic cholangiocarcinoma: a case report.

Authors:  Guo-Liang Yao
Journal:  World J Surg Oncol       Date:  2022-06-09       Impact factor: 3.253

Review 3.  Laparoscopic liver resection: indications, limitations, and economic aspects.

Authors:  Moritz Schmelzle; Felix Krenzien; Wenzel Schöning; Johann Pratschke
Journal:  Langenbecks Arch Surg       Date:  2020-07-01       Impact factor: 3.445

4.  Robotic Extrahepatic Biliary Resection with Roux-en-Y Hepaticojejunostomy for Type 2 Klatskin Tumor.

Authors:  Iswanto Sucandy; Sharona B Ross; Kaitlyn L Crespo; Alexander S Rosemurgy
Journal:  Ann Surg Oncol       Date:  2021-08-09       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.